Bacterin to Present at the Leerink Global Healthcare Conference

Leerink Global Healthcare Conference 2014

BELGRADE, Mont.--()--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO, Dan Goldberger, and CFO, John Gandolfo, will present at the Leerink Global Healthcare Conference, to be held February 12-13, 2014 at the Waldorf Astoria Hotel in New York. Bacterin's presentation will take place Thursday February 13, 2014 at 3:30 PM EST.

A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Info" section of the Company's website at www.bacterin.com. A replay of the conference presentation will also be available.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses coatings for various medical device applications. For further information, please visit www.bacterin.com.

Contacts

COCKRELL GROUP
Rich Cockrell, 877-889-1972
investorrelations@thecockrellgroup.com
cockrellgroup.com

Release Summary

Bacterin to present at Leering Global Healthcare Conference

Sharing

Contacts

COCKRELL GROUP
Rich Cockrell, 877-889-1972
investorrelations@thecockrellgroup.com
cockrellgroup.com